Oh CR, Kim JE, Hong YS, Kim SY, et al. Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer. Int J Cancer 2022 Feb 18. doi: 10.1002/ijc.33966.
PMID: 35179785